Neural Transplantation in Huntington's Disease

Cellular Transplantation

Volumn , Issue , 2007, Pages 417-437

  Rosser, Anne E ^a   Dunnett, Stephen B ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052528491     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369415-7/50025-9     Document Type: Chapter

References (188)

1. Directive 2004/23/EC on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cel. Official Journal of the European Union, 1904 2004, 48-58. 31 March. E.P.A. Council (Ed.).
2. Guidance on the supply of fetal tissue for research, diagnosis and therapy 1995, D.O. Health (Ed.).
3. The Huntington's Disease Collaborative Research Group. Anovel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
4. Aihara N., Mizukawa K., Koide K., Mabe H., Nishino H. Striatal grafts in infarct striatopallidum increase GABA release, reorganize GABAAreceptor and improve water-maze learning in the rat. Brain Res Bull 1994, 33:483-488.
5. Andreassen O.A., Ferrante R.J., Dedeoglu A., Beal M.F. Lipoic acid improves survival in transgenic mouse models of Huntington's disease. Neuroreport 2001, 12:3371-3373.
6. Bachoud-Lévi A., Bourdet C., Brugières P., Nguyen J.P., Grandmougin T., Haddad B., Jény R., Bartolomeo P., Boisse M.F., Barba G.D., Degos J.D., Ergis A.M., Lefaucheur J.P., Lisovoski F., Pailhous E., Rémy P., Palfi S., Defer G.L., Césaro P., Hantraye P., Peschanski M. Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease. Exp Neurol 2000, 161:194-202.
7. Bachoud-Lévi A.C., Maison P., Bartolomeo P., Boisse M.F., Dalla Barba G., Ergis A.M., Baudic S., Degos J.D., Césaro P., Peschanski M. Retest effects and cognitive decline in longitudinal follow-up of patients with early HD. Neurology 2001, 56:1052-1058.
8. Bachoud-Lévi A.C., Rémy P., Nguyen J.P., Brugières P., Lefaucheur J.P., Bourdet C., Baudic S., Gaura V., Maison P., Haddad B., Boisse M.F., Grandmougin T., Jény R., Bartolomeo P., Dalla Barba G., Degos J.D., Lisovoski F., Ergis A.M., Pailhous E., Césaro P., Hantraye P., Peschanski M. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 2000, 356:1975-1979.
9. Beal M., Kowal B., Ellison D., Mazurek M., Swartz K., Martin J. Replication of the neurochemical characteristics Huntington's disease by quinolinic acid. Nature 1986, 321:168-171.
10. Beal M.F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?. Ann Neurol 1992, 31:119-130.
11. Beal M.F., Brouillet E., Jenkins B., Henshaw R., Rosen B., Hyman B.T. Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J Neurochem 1993, 61:1147-1150.
12. Beal M.F., Brouillet E., Jenkins B.G., Ferrante R.J., Kowall N.W., Miller J.M., Storey E., Srivastava R., Rosen B.R., Hyman B.T. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 1993, 13:4181-4192.
13. Beal M.F., Ferrante R.J. Experimental therapeutics in transgenic mouse models of Huntington's disease. Nat Rev Neurosci 2004, 5:373-384.
14. Beal M.F., Hyman B.T., Koroshetz W. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?. Trends Neurosci 1993, 16:125-131.
15. Ben-Ari Y., Cossart R. Kainate, a double agent that generates seizures: Two decades of progress. Trends Neurosci 2000, 23:580-587.
16. Bensadoun J.C., Brooks S.P., Dunnett S.B. Free operant and discrete trial performance of mice in the nine-hole box apparatus: Validation using amphetamine and scopolamine. Psychopharmacology (Berl) 2004, 174:396-405.
17. Besret L., Kendall A.L., Dunnett S.B. Aspects of PET imaging relevant to the assessment of striatal transplantation in Huntington's disease. J Anat 2000, 196:597-607. (Pt 4).
18. Björklund A., Lindvall O., Isacson O., Brundin P., Wictorin K., Strecker R.E., Clarke D.J., Dunnett S.B. Mechanisms of action of intracerebral neural implants: Studies on nigral and striatal grafts to the lesioned striatum. Trends Neurosci 1987, 10:509-516.
19. Boer G.J. Ethical guidelines for the use of human embryonic or fetal tissue for experimental and clinical neurotransplantation and research. Network of European CNS Transplantation and Restoration (NECTAR). J Neurol 1994, 242:1-13.
20. Boer G.J. Ethical issues in neurografting of human embryonic cells. Theor Med Bioeth 1999, 20:461-475.
21. Boer G.J., Widner H. Clinical neurotransplantation: Core assessment protocol rather than sham surgery as control. Brain Res Bull 2002, 58:547-553.
22. Borlongan C.V., Cahill D.W., Sanberg P.R. Asymmetrical behavior in rats following striatal lesions and fetal transplants: The elevated body swing test. Rest Neurol Neurosci 1995, 9:15-19.
23. Borlongan C.V., Koutouzis T.K., Poulos S.G., Saporta S., Sanberg P.R. Bilateral fetal striatal grafts in the 3-nitropropionic acid-induced hypoactive model of Huntington's disease. Cell Transplant 1998, 7:131-135.
24. Borlongan C.V., Koutouzis T.K., Randall T.S., Freeman T.B., Cahill D.W., Sanberg P.R. Systemic 3-nitropropionic acid: Behavioral deficits and striatal damage in adult rats. Brain Res Bull 1995, 36:549-556.
25. Borlongan C.V., Koutouzis T.K., Sanberg P.R. 3-Nitropropionic acid animal model and Huntington's disease. Neurosci Biobehav Rev 1997, 21:289-293.
26. Brasted P.J., Watts C., Robbins T.W., Dunnett S.B. Associative plasticity in striatal transplants. Proc Natl Acad Sci USA 1999, 96:10524-10529.
27. Brasted P.J., Watts C., Torres E.M., Robbins T.W., Dunnett S.B. Behavioral recovery after transplantation into a rat model of Huntington's disease: Dependence on anatomical connectivity and extensive postoperative training. Behav Neurosci 2000, 114:431-436.
28. Brooks S.P., Pask T., Jones L., Dunnett S.B. Behavioural profiles of inbred mouse strains used as transgenic backgrounds. I: Motor tests. Genes Brain Behav 2004, 3:206-215.
29. Brooks S.P., Pask T., Jones L., Dunnett S.B. Behavioural profiles of inbred mouse strains used as transgenic backgrounds. II: Cognitive tests. Genes Brain Behav 2005, 4:307-317.
30. Brown V.J., Robbins T.W. Elementary processes of response selection mediated by distinct regions of the striatum. J Neurosci 1989, 9:3760-3765.
31. Browne S.E., Bowling A.C., MacGarvey U., Baik M.J., Berger S.C., Muqit M.M., Bird E.D., Beal M.F. Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia. Ann Neurol 1997, 41:646-653.
32. Brundin P., Fricker R.A., Nakao N. Paucity of P-zones in striatal grafts prohibit commencement of clinical trials in Huntington's disease. Neuroscience 1996, 71:895-897.
33. Burd L., Gregory J.M., Kerbeshian J. The brain-mind quiddity: Ethical issues in the use of human brain tissue for therapeutic and scientific purposes. J Med Ethics 1998, 24:118-122.
34. Butler H., Juurlink B.H.J. An atlas for staging mammalian and chick embryos 1987, CRC Press, Boca Raton.
35. Calabresi P., Pisani A., Mercuri N.B., Bernardi G. Longterm potentiation in the striatum is unmasked by removing the voltage-dependent magnesium block of NMDA receptor channels. Eur J Neurosci 1992, 4:929-935.
36. Carli M., Evenden J.L., Robbins T.W. Depletion of unilateral striatal dopamine impairs initiation of contralateral actions and not sensory attention. Nature 1985, 313:679-682.
37. Carter R.J., Lione L.A., Humby T., Mangiarini L., Mahal A., Bates G.P., Dunnett S.B., Morton A.J. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci 1999, 19:3248-3257.
38. Choi D.W. Cerebral hypoxia: Some new approaches and unanswered questions. J Neurosci 1990, 10:2493-2501.
39. Clarke D.J., Dunnett S.B. Synaptic relationships between cortical and dopaminergic inputs and intrinsic GABAergic systems within intrastriatal striatal grafts. J Chem Neuroanat 1993, 6:147-158.
40. Clarke D.J., Wictorin K., Dunnett S.B., Bolam J.P. Internal composition of striatal grafts: Light and electron microscopy. The Basal Ganglia IV. New Ideas on Structure and Function 1994, 189-196. Plenum Press, New York. G. Percheron, J.S. McKenzie, J. Féger (Eds.).
41. Coyle J.T., Schwarcz R. Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea. Nature 1976, 263:244-246.
42. Davies S.W., Turmaine M., Cozens B.A., DiFiglia M., Sharp A.H., Ross C.A., Scherzinger E., Wanker E.E., Mangiarini L., Bates G.P. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997, 90:537-548.
43. de Almeida L.P., Ross C.A., Zala D., Aebischer P., Deglon N. Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingti expression levels, and protein length. J Neurosci 2002, 22:3473-3483.
44. de la Cuetara-Bernal K. Fetal nerve tissue, ethics and transplants. Rev Neurol 1998, 27:1043-1049.
45. Deacon T., Schumacher J., Dinsmore J., Thomas C., Palmer P., Kott S., Edge A., Penney D., Kassissieh S., Dempsey P., Isacson O. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat Med 1997, 3:350-353.
46. Deacon T.W., Pakzaban P., Isacson O. The lateral ganglionic eminence is the origin of cells committed to striatal phenotypes: Neural transplantation and developmental evidence. Brain Res 1994, 668:211-219.
47. Deckel A.W., Moran T.H., Coyle J.T., Sanberg P.R., Robinson R.G. Anatomical predictors of behavioral recovery following fetal striatal transplants. Brain Res 1986, 365:249-258.
48. Deckel A.W., Robinson R.G., Coyle J.T., Sanberg P.R. Reversal of long-term locomotor abnormalities in the kainic acid model of Huntington's disease by day 18 fetal striatal implants. Eur J Pharmacol 1983, 93:287-288.
49. Dedeoglu A., Kubilus J.K., Jeitner T.M., Matson S.A., Bogdanov M., Kowall N.W., Matson W.R., Cooper A.J., Ratan R.R., Beal M.F., Hersch S.M., Ferrante R.J. Therapeutic effects of cystamine in a murine model of Huntington's disease. J Neurosci 2002, 22:8942-8950.
50. Denys A., Leroy-Willig A., Riche D., Hantraye P. MR appearance of neural grafts in a primate model of Huntington disease. AJR Am J Roentgenol 1992, 158:215-216.
51. DiFiglia M., Sapp E., Chase K.O., Davies S.W., Bates G.P., Vonsattel J.P., Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997, 277:1990-1993.
52. Divac I., Markowitsch H.J., Pritzel M. Behavioral and anatomical consequences of small intrastriatal injections of kainic acid in the rat. Brain Res 1978, 151:523-532.
53. Divac I., Rosvold H.E., Szwarcbart M.K. Behavioral effects of selective ablation of the caudate nucleus. J Comp Physiol Psychol 1967, 63:184-190.
54. Dobrossy M.D., Dunnett S.B. The influence of environment and experience on neural grafts. Nat Rev Neurosci 2001, 2:871-879.
55. Dobrossy M.D., Dunnett S.B. Striatal grafts alleviate deficits in response execution in a lateralised reaction time task. Brain Res Bull 1998, 47:585-593.
56. Dunnett S.B. Functional repair of striatal systems by neural transplants: Evidence for circuit reconstruction. Behav Brain Res 1995, 66:133-142.
57. Dunnett S.B., Bensadoun J.C., Pask T., Brooks S.P. Assessment of motor behaviour in transgenic mice. Mouse Behaviour Phenotyping 2003, 1-12. Society of Neuroscience, Washington. J.N. Crawley (Ed.).
58. Dunnett S.B., Björklund A., Lindvall O. Cell therapy in Parkinson's disease: Stop or go?. Nat Rev Neurosci 2001, 2:365-369.
59. Dunnett S.B., Björklund A. Mechanisms of function of neural grafts in the injured brain. Functional Neural Transplantation 1994, 531-567. Raven Press, New York. S.B. Dunnett, A. Björklund (Eds.).
60. Dunnett S.B., Carter R.J., Watts C., Torres E.M., Mahal A., Mangiarini L., Bates G., Morton A.J. Striatal transplantation in a transgenic mouse model of Huntington's disease. Exp Neurol 1998, 154:31-40.
61. Dunnett S.B., Isacson O., Sirinathsinghji D.J., Clarke D.J., Björklund A. Striatal grafts in rats with unilateral neostriatal lesions. III. Recovery from dopamine-dependent motor asymmetry and deficits in skilled paw reaching. Neuroscience 1988, 24:813-820.
62. Dunnett S.B., Iversen S.D. Learning impairments following selective kainic acid-induced lesions within the neostriatum of rats. Behav Brain Res 1981, 2:189-209.
63. Dunnett S.B., Iversen S.D. Regulatory impairments following selective kainic acid lesions of the neostriatum. Behav Brain Res 1980, 1:497-506.
64. Dunnett S.B., Meldrum A., Muir J.L. Frontal-striatal disconnection disrupts cognitive performance of the frontal-type in the rat. Neuroscience 2005, 155:1055-1065.
65. Dunnett S.B., Nathwani F., Björklund A. The integration and function of striatal grafts. Prog Brain Res 2000, 127:345-380.
66. Dunnett S.B., Rosser A.E. Cell therapy in Huntington's disease. NeuroRx 2004, 1:394-405.
67. Dunnett S.B., White A. Striatal grafts alleviate bilateral striatal lesion deficits in operant delayed alternation in the rat. Exp Neurol 2006, 199:479-489.
68. Farrington M., Wreghitt T.G., Lever A.M., Dunnett S.B., Rosser A.E., Barker R.A. Neural transplantation in Huntington's disease: NEST-UK donor tissue microbiological screening programme and review of the literature. Cell Transpl 2005.
69. Fawcett J.W., Rosser A.E., Dunnett S.B. Brain damage, brain repair 2001, Oxford University Press, Oxford and New York.
70. Ferrante R.J., Kowall N.W., Beal M.F., Richardson E.P., Bird E.D., Martin J.B. Selective sparing of a class of striatal neurons in Huntington's disease. Science 1985, 230:561-563.
71. Fink J.S., Schumacher J.M., Ellias S.L., Palmer E.P., Saint-Hilaire M., Shannon K., Penn R., Starr P., VanHorne C., Kott H.S., Dempsey P.K., Fischman A.J., Raineri R., Manhart C., Dinsmore J., Isacson O. Porcine xenografts in Parkinson's disease and Huntington's disease patients: Preliminary results. Cell Transplant 2000, 9:273-278.
72. Folkerth R.D., Durso R. Survival and proliferation of nonneural tissues, with obstruction of cerebral ventricles, in a parkinsonian patient treated with fetal allografts. Neurology 1996, 46:1219-1225.
73. Freed C.R., Greene P.E., Breeze R.E., Tsai W.Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J.Q., Eidelberg D., Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001, 344:710-719.
74. Freeman T.B., Cicchetti F., Hauser R.A., Deacon T.W., Li X.J., Hersch S.M., Nauert G.M., Sanberg P.R., Kordower J.H., Saporta S., Isacson O. Transplanted fetal striatum in Huntington's disease: Phenotypic development and lack of pathology. Proc Natl Acad Sci USA 2000, 97:13877-13882.
75. Freeman T.B., Vawter D., Goetz C.G., Leaverton P.E., Hauser R.A., Sanberg P.R., Godbold J.H., Olanow C.W. Toward the use of surgical placebo-controlled trials. Transplant Proc 1997, 29:1925.
76. Fricker R.A., Barker R.A., Fawcett J.W., Dunnett S.B. A comparative study of preparation techniques for improving the viability of striatal grafts using vital stains, in vitro cultures, and in vivo grafts. Cell Transplant 1996, 5:599-611.
77. Fricker R.A., Torres E.M., Dunnett S.B. The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. I. Morphological characteristics. Neuroscience 1997, 79:695-710.
78. Fricker R.A., Torres E.M., Hume S.P., Myers R., Opacka-Juffrey J., Ashworth S., Brooks D.J., Dunnett S.B. The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. II. Correlation between positron emission tomogra and reaching behaviour. Neuroscience 1997, 79:711-721.
79. Gaffan D.Memory action and the corpus striatum: Current developments in the memory-habit distinction. Semin Neurosci 1996, 8:33-38.
80. Gaura V., Bachoud-Lévi A.C., Ribeiro M.J., Nguyen J.P., Frouin V., Baudic S., Brugières P., Mangin J.F., Boisse M.F., Palfi S., Césaro P., Samson Y., Hantraye P., Peschanski M., Rémy P. Striatal neural grafting improves cortical metabolism in Huntington's disease patients. Brain 2004, 127:65-72.
81. Giordano M., Ford L.M., Shipley M.T., Sanberg P.R. Neural grafts and pharmacological intervention in a model of Huntington's disease. Brain Res Bull 1990, 25:453-465.
82. Giordano M., Salado-Castillo R., Sanchez-Alvarez M., Prado-Alcala R.A. Striatal transplants prevent AF64Ainduced retention deficits. Life Sci 1998, 63:1953-1961.
83. Grasbon-Frodl E.M., Nakao N., Lindvall O., Brundin P. Developmental features of human striatal tissue transplanted in a rat model of Huntington's disease. Neurobiol Dis 1997, 3:299-311.
84. Grasbon-Frodl E.M., Nakao N., Lindvall O., Brundin P. Phenotypic development of the human embryonic striatal primordium: A study of cultured and grafted neurons from the lateral and medial ganglionic eminences. Neuroscience 1996, 73:171-183.
85. Graybiel A.M. The basal ganglia and chunking of action repertoires. Neurobiol Learn Mem 1998, 70:119-136.
86. Graybiel A.M., Liu F.C., Dunnett S.B. Intrastriatal grafts derived from fetal striatal primordia. I. Phenotype and modular organization. J Neurosci 1989, 9:3250-3271.
87. Guldin W.O., Markowitsch H.J. No detectable remote lesions following massive intrastriatal injections of ibotenic acid. Brain Res 1981, 225:446-451.
88. Gusella J.F., Wexler N.S., Conneally P.M., Naylor S.L., Anderson M.A., Tanzi R.E., Watkins P.C., Ottina K., Wallace M.R., Sakaguchi A.Y., et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983, 306:234-238.
89. Gutekunst C.A., Norflus F., Hersch S.M. The neuropathology of Huntington's disease. Huntington's Disease 2002, 251-275. Oxford University Press, Oxford and New York. G. Bates, P. Harper, L. Jones (Eds.).
90. Guzman R., Meyer M., Lovblad K.O., Ozdoba C., Schroth G., Seiler R.W., Widmer H.R. Striatal grafts in a rat model of Huntington's disease: Time course comparison of MRI and histology. Exp Neurol 1999, 156:180-190.
91. Hantraye P., Riche D., Maziere M., Isacson O. Intrastriatal transplantation of cross-species fetal striatal cells reduces abnormal movements in a primate model of Huntington disease. Proc Natl Acad Sci USA 1992, 89:4187-4191.
92. Hauser R.A., Furtado S., Cimino C.R., Delgado H., Eichler S., Schwartz S., Scott D., Nauert G.M., Soety E., Sossi V., Holt D.A., Sanberg P.R., Stoessl A.J., Freeman T.B. Bilateral human fetal striatal transplantation in Huntington's disease. Neurology 2002, 58:687-695.
93. Helm G.A., Palmer P.E., Simmons N.E., diPierro C., Bennett J.P. Descriptive morphology of developing fetal neostriatal allografts in the rhesus monkey: A correlated light and electron microscopic Golgi study. Neuroscience 1992, 50:163-179.
94. Heyes M.P., Saito K., Crowley J.S., Davis L.E., Demitrack M.A., Der M., Dilling L.A., Elia J., Kruesi M.J., Lackner A., et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 1992, 115:1249-1273. (Pt 5).
95. Ho A.K., Sahakian B.J., Brown R.G., Barker R.A., Hodges J.R., Ane M.N., Snowden J., Thompson J., Esmonde T., Gentry R., Moore J.W., Bodner T. Profile of cognitive progression in early Huntington's disease. Neurology 2003, 61:1702-1706.
96. Hoang T.Q., Bluml S., Dubowitz D.J., Moats R., Kopyov O., Jacques D., Ross B.D. Quantitative protondecoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases. Neurology 1998, 50:1033-1040.
97. Hodgson J.G., Agopyan N., Gutekunst C.A., Leavitt B.R., LePiane F., Singaraja R., Smith D.J., Bissada N., McCutcheon K., Nasir J., Jamot L., Li X.J., Stevens M.E., Rosemond E., Roder J.C., Phillips A.G., Rubin E.M., Hersch S.M., Hayden M.R. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 1999, 23:181-192.
98. Hughes R.E., Olson J.M. Therapeutic opportunities in polyglutamine disease. Nat Med 2001, 7:419-423.
99. Huntington G. On chorea. Adv Neurol 1872, 1:33-35.
100. Hurelbrink C.B., Armstrong R.J., Barker R.A., Dunnett S.B., Rosser A.E. Hibernated human fetal striatal tissue: Successful transplantation in a rat model of Huntington's disease. Cell Transplant 2000, 9:743-749.
101. Hurelbrink C.B., Tyers P., Armstrong R.J., Dunnett S.B., Barker R.A., Rosser A.E. Long-term hibernation of human fetal striatal tissue does not adversely affect its differentiation in vitro or graft survival: Implications for clinical trial in Huntington's disease. Cell Transplant 2003, 12:687-695.
102. Isacson O., Brundin P., Kelly P.A., Gage F.H., Björklund A. Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned rat striatum. Nature 1984, 311:458-460.
103. Isacson O., Dawbarn D., Brundin P., Gage F.H., Emson P.C., Björklund A. Neural grafting in a rat model of Huntington's disease: Striosomal-like organization of striatal grafts as revealed by acetylcholinesterase histochemistry, immunocytochemistry and receptor autoradiography. Neuroscience 1987, 22:481-497.
104. Isacson O., Dunnett S.B., Björklund A. Graft-induced behavioral recovery in an animal model of Huntington disease. Proc Natl Acad Sci USA 1986, 83:2728-2732.
105. Isacson O., Riche D., Hantraye P., Sofroniew M.V., Maziere M. A primate model of Huntington's disease: Crossspecies implantation of striatal precursor cells to the excitotoxically lesioned baboon caudate-putamen. Exp Brain Res 1989, 75:213-220.
106. Jones L. The cell biology of Huntington's disease. Huntington's Disease 2002, 348-386. Oxford University Press, Oxford and New York. G. Bates, P. Harper, L. Jones (Eds.).
107. Kelly C.M., Rosser A.E., Dunnett S.B. Neuronal cells for transplantation in Huntington's disease. Cell Therapy for Brain Repair 2006, Humana Press, Totowa. P.R. Sanberg, C.D. Davis (Eds.).
108. Kendall A.L., Hantraye P., Palfi S. Striatal tissue transplantation in non-human primates. Prog Brain Res 2000, 127:381-404.
109. Kendall A.L., Rayment F.D., Torres E.M., Baker H.F., Ridley R.M., Dunnett S.B. Functional integration of striatal allografts in a primate model of Huntington's disease. Nat Med 1998, 4:727-729.
110. Kieburtz K., Penney J.B., Como P., Ranen N., Shoulson I., et al. Unified Huntington's disease rating scale: Reliability and consistency. Mov Disord 1996, 11:136-142.
111. Koide K., Hashitani T., Aihara N., Mabe H., Nishino H. Improvement of passive avoidance task after grafting of fetal striatal cell suspensions in ischemic striatum in the rat. Rest Neurol Neurosci 1993, 5:205-214.
112. Kopyov O.V., Jacques S., Kurth M., Philpott L.M., Lee A., Patterson M., Duma C., Lieberman A., Eagle K.S. Fetal transplantation for Huntington's disease: Clinical studies. Cell Transplantation for Neurological Disorders 1998, 95-134. NJ, Humana Press, Totowa. T.B. Freeman, J.H. Kordower (Eds.).
113. Kopyov O.V., Jacques S., Lieberman A., Duma C.M., Eagle K.S. Safety of intrastriatal neurotransplantation for Huntington's disease patients. Exp Neurol 1998, 149:97-108.
114. Kremer B. Clinical neurology of Huntington's disease. Huntington's Disease 2002, 28-61. Oxford University Press, Oxford and New York. G.P. Bates, P.S. Harper, A.L. Jones (Eds.).
115. Lione L.A., Carter R.J., Hunt M.J., Bates G.P., Morton A.J., Dunnett S.B. Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J Neurosci 1999, 19:10428-10437.
116. Madrazo I., Franco-Bourland R.E., Castrejon H., Cuevas C., Ostrosky-Solis F. Fetal striatal homotransplantation for Huntington's disease: First two case reports. Neurol Res 1995, 17:312-315.
117. Magendie F. Note sur les fonctions des corps striés et des tuberclules quadrijumeaux. Physiol Exp Pathol 1823, 3:376-381.
118. Mamelak A.N., Eggerding F.A., Oh D.S., Wilson E., Davis R.L., Spitzer R., Hay J.A., Caton W.L. Fatal cyst formation after fetal mesencephalic allograft transplant for Parkinson's disease. J Neurosurg 1998, 89:592-598.
119. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S.W., Bates G.P. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87:493-506.
120. Marin O., Anderson S.A., Rubenstein J.L. Origin and molecular specification of striatal interneurons. J Neurosci 2000, 20:6063-6076.
121. Mason S.T., Sanberg P.R., Fibiger H.C. Kainic acid lesions of the striatum dissociate amphetamine and apomorphine stereotype: Similarities to Huntington's chorea. Science 1978, 201:352-355.
122. Mayer E., Brown V.J., Dunnett S.B., Robbins T.W. Striatal graft-associated recovery of a lesion-induced performance deficit in the rat requires learning to use the transplant. Eur J Neurosci 1992, 4:119-126.
123. Mazzocchi-Jones D., Döbrössy M.D., Dunnett S.B. Synaptic plasticity in striatal grafts. The Basal Ganglia VIII 2005, 313-320. Springer, New York. J.P. Bolam, C.A. Ingham, P.J. Magill (Eds.).
124. McGeer E.G., McGeer P.L. Duplication of biochemical changes of Huntington's chorea by intrastriatal injections of glutamic and kainic acids. Nature 1976, 263:517-519.
125. McGeer E.G., Olney J.W., McGeer P.L. Kainic acid as a tool in neurobiology 1978, Raven Press, New York.
126. Menalled L.B., Chesselet M.F. Mouse models of Huntington's disease. Trends Pharmacol Sci 2002, 23:32-39.
127. Mishkin M., Malamut B., Bachevalier J. Memories and habits: Two neural systems. Neurobiology of Learning and Memory 1984, 65-77. Guilford Press, New York. G. Lynch, J.L. McGaugh, N.M. Weinberger (Eds.).
128. Mittleman G., Brown V.J., Robbins T.W. Intentional neglect following unilateral ibotenic acid lesions of the striatum. Neurosci Res Comm 1988, 2:1-8.
129. Montoya C.P., Astell S., Dunnett S.B. Effects of nigral and striatal grafts on skilled forelimb use in the rat. Prog Brain Res 1990, 82:459-466.
130. Morton A.J., Hunt M.J., Hodges A.K., Lewis P.D., Redfern A.J., Dunnett S.B., Jones L. A combination drug therapy improves cognition and reverses gene expression changes in a mouse model of Huntington's disease. Eur J Neurosci 2005, 21:855-870.
131. Morton A.J., Lagan M.A., Skepper J.N., Dunnett S.B. Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington's disease mutation. J Neurocytol 2000, 29:679-702.
132. Murphy K.P., Carter R.J., Lione L.A., Mangiarini L., Mahal A., Bates G.P., Dunnett S.B., Morton A.J. Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation. J Neurosci 2000, 20:5115-5123.
133. Naimi S., Jény R., Hantraye P., Peschanski M., Riche D. Ontogeny of human striatal DARPP-32 neurons in fetuses and following xenografting to the adult rat brain. Exp Neurol 1996, 137:15-25.
134. Nakao N., Odin P., Brundin P. Selective sub-dissection of the striatal primordium for cultures affects the yield of DARPP-32-containing neurones. Neuroreport 1994, 5:1081-1084.
135. Nishino H., Aihara N., Czurko A., Hashitani T., Isobe Y., Ichikawa O., Watari H. Reconstruction of GABAergic transmission and behavior by striatal cell grafts in rats with ischemic infarcts in the middle cerebral artery. J Neural Transplant Plast 1993, 4:147-155.
136. Norman A.B., Giordano M., Sanberg P.R. Fetal striatal tissue grafts into excitotoxin-lesioned striatum: Pharmacological and behavioral aspects. Pharmacol Biochem Behav 1989, 34:139-147.
137. Norman A.B., Thomas S.R., Pratt R.G., Samaratunga R.C., Sanberg P.R. A magnetic resonance imaging contrast agent differentiates between the vascular properties of fetal striatal tissue transplants and gliomas in rat brain in vi. Brain Res 1989, 503:156-159.
138. Norman A.B., Thomas S.R., Pratt R.G., Samaratunga R.C., Sanberg P.R. Magnetic resonance imaging of rat brain following kainic acid-induced lesions and fetal striatal tissue transplants. Brain Res 1989, 483:188-191.
139. Olanow C.W., Arendash G.W. Metals and free radicals in neurodegeneration. Curr Opin Neurol 1994, 7:548-558.
140. Olanow C.W., Goetz C.G., Kordower J.H., Stoessl A.J., Sossi V., Brin M.F., Shannon K.M., Nauert G.M., Perl D.P., Godbold J., Freeman T.B. A doubleblind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003, 54:403-414.
141. Olsson M., Campbell K., Wictorin K., Björklund A. Projection neurons in fetal striatal transplants are predominantly derived from the lateral ganglionic eminence. Neuroscience 1995, 69:1169-1182.
142. Pakzaban P., Deacon T.W., Burns L.H., Dinsmore J., Isacson O. A novel mode of immunoprotection of neural xenotransplants: Masking of donor major histocompatibility complex class I enhances transplant survival in the cent nervous system. Neuroscience 1995, 65:983-996.
143. Pakzaban P., Deacon T.W., Burns L.H., Isacson O. Increased proportion of acetylcholinesterase-rich zones and improved morphological integration in host striatum of fetal grafts derived from the lateral but n medial ganglionic eminence. Exp Brain Res 1993, 97:13-22.
144. Palfi S., Conde F., Riche D., Brouillet E., Dautry C., Mittoux V., Chibois A., Peschanski M., Hantraye P. Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease. Nat Med 1998, 4:963-966.
145. Palfi S., Ferrante R.J., Brouillet E., Beal M.F., Dolan R., Guyot M.C., Peschanski M., Hantraye P. Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease. J Neurosci 1996, 16:3019-3025.
146. Palfi S., Nguyen J.P., Brugières P., Le Guerinel C., Hantraye P., Rémy P., Rostaing S., Defer G.L., Césaro P., Keravel Y., Peschanski M. MRI-stereotactical approach for neural grafting in basal ganglia disorders. Exp Neurol 1998, 150:272-281.
147. Peschanski M., Césaro P., Hantraye P. Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease. Neuroscience 1995, 68:273-285.
148. Philpott L.M., Kopyov O.V., Lee A.J., Jacques S., Duma C.M., Caine S., Yang M., Eagle K.S. Neuropsychological functioning following fetal striatal transplantation in Huntington's chorea: Three case presentations. Cell Transplant 1997, 6:203-212.
149. Pina A.L., Ormsby C.E., Bermudez-Rattoni F. Differential recovery of inhibitory avoidance learning by striatal cortical, and mesencephalic fetal grafts. Behav Neural Biol 1994, 61:196-201.
150. Pisa M., Sanberg P.R., Fibiger H.C. Locomotor activity, exploration and spatial alternation learning in rats with striatal injections of kainic acid. Physiol Behav 1980, 24:11-19.
151. Polkinghorne J., Hoffenberg R., Kennedy I., Macintyre S. Review of the guidance on the research use of fetuses and fetal material 1989, HMSO, London.
152. Pundt L.L., Kondoh T., Conrad J.A., Low W.C. Transplantation of human fetal striatum into a rodent model of Huntington's disease ameliorates locomotor deficits. Neurosci Res 1996, 24:415-420.
153. Pundt L.L., Kondoh T., Conrad J.A., Low W.C. Transplantation of human striatal tissue into a rodent model of Huntington's disease: Phenotypic expression of transplanted neurons and host-to-graft innervat. Brain Res Bull 1996, 39:23-32.
154. Pundt L.L., Narang N., Kondoh T., Low W.C. Localization of dopamine receptors and associated mRNA in transplants of human fetal striatal tissue in rodents with experimental Huntington's disease. Neurosci Res 1997, 27:305-315.
155. Quinn N., Brown R., Craufurd D., Goldman S., Hodges J., Kieburtz K., Lindvall O., MacMillan J., Roos R. Core Assessment Program for Intracerebral Transplantation in Huntington's Disease (CAPIT-HD). Mov Disord 1996, 11:143-150.
156. Reading P.J., Dunnett S.B. Embryonic striatal grafts reverse the disinhibitory effects of ibotenic acid lesions of the ventral striatum. Exp Brain Res 1995, 105:76-86.
157. Rebec G.V., Barton S.J., Marseilles A.M., Collins K. Ascorbate treatment attenuates the Huntington behavioral phenotype in mice. Neuroreport 2003, 14:1263-1265.
158. Ross B.D., Hoang T.Q., Bluml S., Dubowitz D., Kopyov O.V., Jacques D.B., Lin A., Seymour K., Tan J. In vivo magnetic resonance spectroscopy of human fetal neural transplants. NMR Biomed 1999, 12:221-236.
159. Rosser A.E., Barker R.A., Armstrong R.J., Elneil S., Jain M., Hurelbrink C.B., Prentice A., Carne C., Thornton S., Hutchinson H., Dunnett S.B. Staging and preparation of human fetal striatal tissue for neural transplantation in Huntington's disease. Cell Transplant 2003, 12:679-686.
160. Rosser A.E., Barker R.A., Harrower T., Watts C., Farrington M., Ho A.K., Burnstein R.M., Menon D.K., Gillard J.H., Pickard J., Dunnett S.B.
161. Rosvold H.E., Delgado J.M. The effect on delayedalternation test performance of stimulating or destroying electrically structures within the frontal lobes of the monkey's brain. J Comp Physiol Psychol 1956, 49:365-372.
162. Rutherford A., Garcia-Munoz M., Dunnett S.B., Arbuthnott G.W. Electrophysiological demonstration of host cortical inputs to striatal grafts. Neurosci Lett 1987, 83:275-281.
163. Sanberg P.R., Coyle J.T. Scientific approaches to Huntington's disease. CRC Crit Rev Clin Neurobiol 1984, 1:1-44.
164. Sanberg P.R., Fibiger H.C. Body weight, feeding and drinking behaviors in rats with kainic acid lesions of striatal neurons: With a note on body weight symptomatology in Huntington's di. Exp Neurol 1978, 66:444-466.
165. Sanberg P.R., Henault M.A., Deckel A.W. Locomotor hyperactivity: Effects of multiple striatal transplants in an animal model of Huntington's disease. Pharmacol Biochem Behav 1986, 25:297-300.
166. Sanberg P.R., Lehmann J., Fibiger H.C. Impaired learning and memory after kainic acid lesions of the striatum:Abehavioral model of Huntington's disease. Brain Res 1978, 149:546-551.
167. Sanberg P.R., Pisa M., Fibiger H.C. Avoidance, operant and locomotor behavior in rats with neostriatal injections of kainic acid. Pharmacol Biochem Behav 1979, 10:137-144.
168. Sauer H., Brundin P. Effects of cool storage on survival and function of intrastriatal ventral mesencephalic grafts. Rest Neurol Neurosci 1991, 2:123-135.
169. Schmidt R.H., Björklund A., Stenevi U. Intracerebral grafting of dissociated CNS tissue suspensions: A new approach for neuronal transplantation to deep brain sites. Brain Res 1981, 218:347-356.
170. Schwarcz R., Hokfelt T., Fuxe K., Jonsson G., Goldstein M., Terenius L. Ibotenic acid-induced neuronal degeneration: A morphological and neurochemical study. Exp Brain Res 1979, 37:199-216.
171. Schwarcz R., Whetsell W.O., Mangano R.M. Quinolinic acid: An endogenous metabolite that produces axon-sparing lesions in rat brain. Science 1983, 219:316-318.
172. Siviy S.M., Walsh J.P., Radisavljevic Z., Cohen R.W., Buchwald N.A., Levine M.S. Evidence for enhanced synaptic excitation in transplanted neostriatal neurons. Exp Neurol 1993, 123:222-234.
173. Smart I.H.M., Sturrock R.R. Ontogeny of the neostriatum. The Neostriatum 1979, 127-146. Pergamon Press, New York. I. Divac, R.G.E. Öberg (Eds.).
174. Sramka M., Rattaj M., Molina H., Vojtassak J., Belan V., Ruzicky E. Stereotactic technique and pathophysiological mechanisms of neurotransplantation in Huntington's chorea. Stereotact Funct Neurosurg 1992, 58:79-83.
175. Torres E.M., Fricker R.A., Hume S.P., Myers R., Opacka-Juffry J., Ashworth S., Brooks D.J., Dunnett S.B. Assessment of striatal graft viability in the rat in vivo using a small diameter PET scanner. Neuroreport 1995, 6:2017-2021.
176. Turner D.A., Kearney W. Scientific and ethical concerns in neural fetal tissue transplantation. Neurosurgery 1993, 33:1031-1037.
177. van Dellen A., Deacon R., York D., Blakemore C., Hannan A.J. Anterior cingulate cortical transplantation in transgenic Huntington's disease mice. Brain Res Bull 2001, 56:313-318.
178. Walsh J.P., Zhou F.C., Hull C.D., Fisher R.S., Levine M.S., Buchwald N.A. Physiological and morphological characterization of striatal neurons transplanted into the striatum of adult rats. Synapse 1988, 2:37-44.
179. Watts C., Brasted P.J., Dunnett S.B. The morphology integration, and functional efficacy of striatal grafts differ between cell suspensions and tissue pieces. Cell Transplant 2000, 9:395-407.
180. Watts C., Dunnett S.B., Rosser A.E. Effect of embryonic donor age and dissection on the DARPP-32 content of cell suspensions used for intrastriatal transplantation. Exp Neurol 1997, 148:271-280.
181. Wheeler V.C., Auerbach W., White J.K., Srinidhi J., Auerbach A., Ryan A., Duyao M.P., Vrbanac V., Weaver M., Gusella J.F., Joyner A.L., MacDonald M.E. Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse. Hum Mol Genet 1999, 8:115-122.
182. Wictorin K., Björklund A. Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum: II. Cortical afferents. Neuroscience 1989, 30:297-311.
183. Wictorin K., Isacson O., Fischer W., Nothias F., Peschanski M., Björklund A. Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum: I. Subcortical afferents. Neuroscience 1988, 27:547-562.
184. Wictorin K., Simerly R.B., Isacson O., Swanson L.W., Björklund A. Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum: III. Efferent projecting graft neurons and their relation to host afferent the grafts. Neuroscience 1989, 30:313-330.
185. Widner H. Immunological issues in rodent and primate transplants. Cell Transplantation for Neurological Disorders 1998, 171-187. NJ, Humana Press, Totowa. T.B. Freeman, H. Widner (Eds.).
186. Widner H. NIH neural transplantation funding. Science 1994, 263:737.
187. Xu Z.C., Wilson C.J., Emson P.C. Synaptic potentials evoked in spiny neurons in rat neostriatal grafts by cortical and thalamic stimulation. J Neurophysiol 1991, 65:477-493.
188. Yamamoto A., Lucas J.J., Hen R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 2000, 101:57-66.